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ABSTRACT 
The develop~llent of nonsurgical co~ltraceptives for cats may facilitate population control 
of the species. The purpose of this study was to investigate the utility of GI&H for 
iinillu~locontraceptio~l of male cats. Male cats (11=12) were divided into groups of tlxee 
and were inunuilized once with 0 (sham), 50, 200, or 400 i g synthetic GI&H coupled to 
keyhole limpet hernocyanin and combined with a nlycobacterial adjuvant to e~lhance 
inullunogenicity. GI&H ailtibody titer, serunl testostero~le concentration, and scrota1 size 
were detenniiled monthly. At 6 1110, semen was collected by electroejaculation and testes 
were examined histologically. GnRH antibodies were detected in all cats receiving GuRH 
vaccine by 1 nlo post-treatment and persisted t l~oughout  he study. No dose effect of 
GnRH was observed as titers were not significantly different between cats treated with 
50, 200, or 400 i g GnRH (P = 0.5). Six of ni11e treated cats were classified as responders 
based on high GIIRH ailtibody titers (>32,000). By 3 mo post-treat~llent, respo~lder cats 
had undetectable testosteroile and testicular atrophy. Nonrespoilder cats had GnRH titers 
of 4,000 to 32,000 and testosterone conce~ltrations intei-nlediate between responder and 
sllailr treated cats. At 6 mo, total spenn counts were similar for shamtreated cats (3.1 i 
1 S x lo6 sperm) and noixesponder cats (3.4 k 1.6 x lo6 sperm; P = 0.7). Only one of the 
six responder cats produced spei-111, none of which were motile. Co~llbined testicular 
weights of respoilder cats (1.3 k 0.1 g) were lower than sha~n-treated coiltrols (5.3 * 1.3 
g; P = 0.02) and ilomesponder cats (2.9 k 0.3 g; P = 0.02). Histologic evaluatioil of the 
testes revealed that in responder cats, the interstitial cells that were present were pale and 
shruilltei~ conlpared to the pluillp, polyhedral eosinophilic cells in shan~treated cats. 
GnRH responder cats had marked tubular atrophy with vacuolated Sertoli cells and a 
paucity of germ cells. SingIe-dose GnRH treatment resulted in testosterone 
concelltrations and semen quality coilsistent with imrnunocastration in a majority of cats 
treated. Suppoited by NIH RR-00 124. 
PROCEEDNGS OF THE IO(!4 ACCD 1YTERN.ATION.AL S5.XlPOSIUhI 
O?; NONSURGIC.AL hIETHODS FOR- PET POPLLATIOX CONTROL 
The d2velopment of no~~surgical  contraceptives for cats may facilitate population control 
of the species. An ideal feline nonsurgical contraceptive would have a high marzin of 
safety for treated aniinals and the en\iiroimlent, be effective ill a high percentaze of 
treated animals, have a rapid onset and long duration of activity following a single 
treatment, inhibit sex hornlone production, be efficacious in all animals regardless of sex 
or age, and be simple to deliver ill the field. Emerging i~~xnunocontraceptive t clmology 
provides a promising avenue for norrsurgical populatioil control. 
When considering the best inxlluilocontraceptive strategy, the highest point along the 
hypothalamic- pituitary- gonadal axis is a logical target. GnRH is a decapeptide prodmed 
in the cat by telencephalic and diencephalic neurons and released fro111 the illedian 
e~nille~lce into the capillary plexus of the hypothalamus. GnRH release initiates a 
honnone cascade responsible for ovulatioil and viable speiln production, as well as 
undesirable ~luisance behaviors such as fighting, marlung, wandering, and calling, and to 
adverse health effects, including inanlnlaly neoplasia, pyometra, and prostatitis. 
Therefore, antibodies against hypothalan~ic GllRH prevent the iloilllal cascade of 
hornlone secretion that is required for ,oonadal regulation and gamete production. The 
purpose of t l is shdy  was to iilvesti,oate the utility of modified gonadotropin releasing 
hornlone (GiiRH) for in~~nu~locontraceptioil of male cats. 
Twelve male cats were raildonlly distributed into four treatnlent groups. Each inale was 
iin~llunized once with a vaccine construct containing either 0 (sham), 50, 200, or 400 i g 
synthetic GilRH coupled to keyhole limpet hernocyanin and combined with a 
~llycobacterial adjuvant to enhance irnmunogenicity. GnRH antibody titer, serum 
testosterone concentration, and scrota1 size were detennined monthly. At 6 months, 
semen was collected by electroejaculatioil and evaluated for coilceiltratioll and motility. 
Males were also castrated at 6 months, and testes were examined histologically. 
GllRW antibodies were detected in all cats receiving GnRH vaccine by 1 month post- 
treat~nent and persisted tllroughout the study. No dose effect of GnRH was observed as 
titers were not significantly different between cats treated with 50, 200, or 400 i g GnRH 
(P = 0.5). Six of nine treated cats were classified as responders based on high GilRH 
antibody titers (>32,000). By 3 months post-treatment, responder cats had undetectable 
testostero~le and testicular atrophy. Noilrespo~lder cats had GnRH titers of 4,000 to 
32,000 and testosterone concentratioils intermediate between responder and sha~n-treated 
cats. 
At 6 mo, total sperm counts were similar for s h a n ~  treated cats (3.1 k 1.8 x lo6  spenn) 
and no~lresponder cats (3.4 + 1.6 x lo6 sperm; P = 0.7). Five of the six respoilding cats 
exhibited azoospennia, with the remaining male producing nonmotile spenn. Combined 
testicular weights of responder cats (1.3 * 0.1 g) were lower than nonresponder cats (2.9 
* 0.3 g; P = 0.02), and shan~treated controls (5.3 * 1.3 g: P = 0.02j. Evaluation of testes 
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c2.1 i -  . . L I , ~  an3 a p z ~ c i t ~ .  of gci-111 ~ ~ 1 1 s .  LI addltml:: the in~erstitia! cclls of rsspolidsr cets \\.ere 
pzle 2i.1d slilunlie11 v).ll=~, coinpared to the plump; polyhedl-a1 eosinophilic cells in s h a m  
treats6 cats. In this pilot shldj-; single-dose GllRH treatnlsnr resulted in kstosterone 
concentl-arions and seiil=.n qua!it>. consistent with inlnluilocastratioll in a mzjority of cats 
treated. 
These results led to de\.elopnlent of a full trial using the 200 ug GnRH vaccine coi~stmct. 
I11 brief, this study consisted of 24 males raildoillly distributed into either a treat~nellt or 
sham group. Deternlillation of GnRH antibodies, seruin testosterone concentration, and 
semen analysis were perfornled monthly. hlaterials and methods were repeated exactlj-. 
At t h e e  months post treatnlent, treated males were clearly divided into 5 responder and 4 
no~u-esponder cats. All seminal characteristics of respolldi~lg cats wore severely reduced 
when corrlpared to sham and no~lrespolldillg cats (P<0.05). This study is ollgoi~lg to 
evaluate the duration of illmullity followiilg a single GliRH illml~ulization. 
Table 1 - GnRW antibody titer, testosteroile concentration, and semen characteristics of 
cats 6 1110 after GnRH immunization. 
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Cat 
1A 
1B 
1C 
2A 
2B 
2C 
3 A  
3B 
3C 
4A 
4B 
4C 
Treatment 
Sham 
Shani 
Sham 
5 0 i g G 1 l R H  
5 0 i g G i l R H  
5 0 i g G l i R H  
200 i g 
GllRH 
200 i g 
GilRH 
200 i g 
GnRH 
400 i g 
GnRH 
400 i g 
GIIRH 
400 i g 
GllRH 
Combined 
testes weight 
(9 
7.1 
3.0 
5.7 
3.0 
1.2 
1.7 
1.3 
2.3 
0.9 
1.5 
1.2 
3 .3 
GnRH 
antibody 
titer (lo3) 
0 
0 
0 
3 2 
256 
125 
128 
3 2 
125 
125 
125 
5 
Serum 
testosterone 
(i g/dL) 
110 
240 
240 
------ 
100 
0 
0 
0 
10 
0 
0 
0 
110 
Total sperm 
count 
(x 1 06) 
6.6 
1.4 
1.2 
1.3 
0 
0.0002 
0 
2.2 
0 
0 
0 
6.6 
